Acute Adverse Reactions to Gadolinium-Based Contrast Agents in CMR
Author(s) -
Oliver Bruder,
Steffen Schneider,
Detlev Nothnagel,
Günter Pilz,
Massimo Lombardi,
Anil M. Sinha,
Anja Wagner,
Thorsten Dill,
Herbert Frank,
Albert C. van Rossum,
Juerg Schwitter,
Eike Nagel,
Jochen Senges,
Georg Sabin,
Udo Sechtem,
Heiko Mahrholdt
Publication year - 2011
Publication title -
jacc. cardiovascular imaging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.79
H-Index - 120
eISSN - 1936-878X
pISSN - 1876-7591
DOI - 10.1016/j.jcmg.2011.06.019
Subject(s) - medicine , gadodiamide , gadolinium , adverse effect , magnetic resonance imaging , nephrogenic systemic fibrosis , coronary artery disease , radiology , nausea , nuclear medicine , cardiology , materials science , metallurgy
The purpose of this study was to assess the frequency, manifestation, and severity of acute adverse reactions associated with administration of several gadolinium-based contrast agents to patients who underwent cardiac magnetic resonance (CMR) imaging in the EuroCMR (European Cardiovascular Magnetic Resonance) Registry multinational and multicenter setting.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom